An interventional study of questionary on quality of life in CHILDREN BORN VERY PRETERM AT SCHOOL-AGE, sponsored by Assistance Publique Hopitaux De Marseille. Completed at 1 site in France. Open to participants aged 7 Years to 9 Years. Per ClinicalTrials.gov, last updated 2017-08-30.
Sponsored by Assistance Publique Hopitaux De Marseille · Not applicable, Interventional, and Other
AIMS The aims were 1) to describe the quality of life (QoL) of a cohort of children born very preterm (\<28 weeks of gestation) aged 7 to 9 years; 2) to compare children's QoL to the QoL reported by a French general population of reference. 3) to determine whether socio-demographic factors, neonatal features and neurocognitive status were impacting their QoL.
METHODS:
PERSPECTIVES This is one of the first studies to collect self-reported data on quality of life of school-age children (7-9 years) born before 28 weeks of gestation. A better understanding of demographic and clinical determinants of QOL of school-age very preterm children may help clinicians involved in the care of these children in their ethical and medical considerations.
2,554 studies on the registry are indexed under Premature Birth; 498 are open to participants now.
This study's enrollment of 350 is above the median of 84 across 1,689 interventional studies indexed under Premature Birth.
Browse Premature Birth studies →Assistance Publique Hopitaux De Marseille is the lead sponsor of 686 studies on the registry; 148 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Other: questionary on quality of life
data on quality of life of school-age children born prematurely
Time frame: 3 years
better understanding of demographic and clinical determinants of QOL of school-age
Time frame: 3 years
This study is completed, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Assistance Publique Hopitaux De Marseille